layoffs
Immunovia to Restructure Operations, Lay Off Employees
The firm said it will stop commercialization of its ImmRay PanCan-d test in the US to focus on developing its next-generation pancreatic cancer detection test.
DermTech to Cut 15 Percent of Workforce in Restructuring to Focus on Skin Cancer Test
The San Diego-based company said it will halt its pipeline programs in order to focus on growing volume and reimbursement for its noninvasive melanoma DNA test.
Biocartis Laying Off 140 Employees as Part of Reorganization Plan
The layoffs, which constitute 25 percent of the company's workforce, are part of a restructuring effort intended to reduce annual operating expenses by €18 million.
SQI Diagnostics Further Cuts Head Count as Possible Shutdown Looms
The company has laid off its chief executive and CSO as it said that it may not be able to continue operations beyond June 15.
T2 Biosystems Lays off 30 Percent of Workforce as Q1 Revenues Drop 71 Percent
The company also announced that it has submitted its T2Biothreat Panel to the US Food and Drug Administration for 510(k) clearance.